ViralVacDB | Details of Viral Vaccine

Details of Viral Vaccine

This Viral vaccine card gives comprehensive information about each vaccine.
Detailed Information
ID10241
Vaccine NameS-268019
Disease NameCOVID-19
Disease ClassificationRespiratory
Virus NameSARS-CoV-2 virus
Nucleic Acid Contentpositive-sense, single-stranded RNA
Vaccine TypeProtein subunit
Vaccine StatusPhase 2
ManufacturerShionogi Inc.
Year of Manufacturing2021
Manufacturing CountryJapan
Age20 - 64 years
DosageNA
Administration RouteIntramuscular
AdjuvantNA
Target StrainNA
DescriptionNA
Approving OrganisationNA
Collaborating OrganisationNA
Other CountriesNA
Trade NameNA
PMIDNA
Clinical Trial IDNA
Reference Linkhttps://jrct.niph.go.jp/en-latest-detail/jRCT2051200092
Additional LinksNA